Global Healthcare Market and Growth Strategy
The Clinical Research Industry
In a highly competitive climate, pharma companies want to see trial data in real
time to allow faster decision-making and planning for later stage trials
Pharma struggles to access real-world data from the health system
Companies must also contract third-parties for secure capture, storage and smart
structuring of data
Data
Needs
80% of clinical research participants indicated that they were
unwilling to visit the trial site for study appointments
Identifying patients for clinical trials is extremely difficult and costly
Subject
Demands
Trial delays are a key driver of costs
Companies have begun implementing digital tools
due to COVID-19 which will save costs in a
post-pandemic world
The FDA and Health Canada have released
guidance for real-world evidence, encouraging
the use of technology
Regulatory
Change
BioPharma
SERVICES INC.
$
Healthcare Delivery
Digitizing
Rising
Costs
|
Clinical research industry is
I
at a tipping point where
digitization will become
essential and conversion to
SaaS will set first-movers
apart.
thinkresearch
TSXV: THNK
14View entire presentation